Intro Pullout Text Widget

Lupus Science & Medicine®

is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.

Impact Factor: 4.687
Citescore: 5.6
All metrics >>

Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.

An official journal of the Lupus Foundation of America (LFA), which is dedicated to advancing the science and medicine of lupus while offering support to patients and their caregivers.

Follow the journal via Twitter and Facebook.

Editors-in-Chief: Professor Jill Buyon, New York University, USA and Professor Ronald van Vollenhoven, Amsterdam University Medical Centers, The Netherlands
Editorial team

Current Issue

Publish in LSM

Lupus Science & Medicine considers submissions of a range of article types, including original research, brief communications, study protocols and meeting reports.

Information is also provided on editorial policies and open access.

This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.

All manuscripts should be submitted online.

Published articles are discoverable via PubMed, Web of Science, Scopus and Google Scholar.

Video: Benefits of publishing in Lupus Science & Medicine

Author information

Submit a paper

Lupus & KCR 2023

Lupus Science & Medicine is delighted to be the official journal of Lupus & KCR 2023, which will be held in Seoul in May 2023.

Abstract submission is open until 2nd December 2022. The abstracts from the conference will be published online in a supplement to Lupus Science & Medicine.

Intro Pullout Text Widget

Lupus Science & Medicine®

Publish in LSM

Latest Articles

Brief communication:

Teratogenic medication use associated with favourable odds of contraception counselling in a cohort of women with systemic lupus erythematosus at a large tertiary academic medical centre

Immunology and inflammation:

Intermuscular adipose tissue in patients with systemic lupus erythematosus

Epidemiology and outcomes:

Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine

Biomarker studies:

Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE

Genetics:

Ancestry, and leucopenia in patients with systemic lupus erythematosus

Lupus & KCR 2023

LSM Podcasts

Most Read Articles

Biomarker studies:

Urine proteomic insights from the belimumab in lupus nephritis trial

Lupus nephritis:

MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT

Epidemiology and outcomes:

2021 DORIS definition of remission in SLE: final recommendations from an international task force

Immunology and inflammation:

CD4 T-cell cooperation promoted pathogenic function of activated naïve B cells of patients with SLE

Review:

Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria

Featured Video

Lupus Science & Medicine

Altmetrics

Twitter Feed

Related Journals